oliverhugo
5年前
The Hash Corporation Appoints Red Light Holland CEO Todd Shapiro to Advisory Board
Toronto, Ontario--(Newsfile Corp. - July 15, 2021) - The Hash Corporation (CSE: REZN) ("Hashco" or the "Company"), a company focusing on the production of hashish and other premium cannabis products using the adaption of old-world traditions, is pleased to announce that it has appointed Todd Shapiro, Chief Executive Officer and Director of Red Light Holland Corp. ("Red Light Holland") to its Advisory Board.
Todd Shapiro has over 20 years of experience as a marketing entrepreneur and brand ambassador having serviced many well established brands including Canopy Growth and Boveda Inc in the Cannabis Industry. As the head of Red Light Holland, Mr. Shapiro, while focusing on building Red Light Holland's brand has developed a global network of contacts in the regulated substance industry, along with a deep understanding of emerging markets, distribution and incredible social media exposure, all of which Hashco hopes to leverage as it positions itself for expansion into the hash and cannabis concentrate market in Canada.
"We are extremely pleased to have Todd join our Advisory Board. He is a visionary with a vast network of connections, and the business acumen necessary to assist Hashco in developing new business opportunities," said Chris Savoie, the Chief Executive Officer and Director of Hashco.
Todd Shapiro is excited to join the team at Hashco and said the following, "We've all heard of hash, but have we all heard of Hashco? I look forward to advising the hard-working team on how to expand their brand name and work within a delicate framework to get as much exposure and distribution as possible."
Todd Shapiro and the Company entered into an advisory board agreement pursuant to which the Company has granted Todd Shapiro an aggregate of 1,000,000 RSUs which will vest quarterly over the first year from the date of issuance. Each vested RSU entitles the holder to receive one common share in the capital of Hashco.
About The Hash Corporation
HashCo is a Canadian company positioning itself to focus on the production and sale of cannabis-based hashish and other cannabis products. HashCo intends to apply its separation and curing techniques to produce a suite of high-quality cannabis resin products, which are all-natural and free of additives and carcinogenic solvents. The Company intends to tailor its product offerings to pay tribute to historic traditions, fragrances and tastes, while upholding the highest health and safety standards.
As of the date of this press release, HashCo is actively seeking and developing partnerships and collaborations with licensed cultivators and other strategic partners within Canada, with the goal of crafting and introducing to the regulated market authentic products which reflect quality and innovation.
For additional information on the Company:
Chris Savoie
Chief Executive Officer and Director
Tel: 1-833-420-7396
Email: chris@hashco.ca
Forward-Looking Statements
Certain information in this news release constitutes forward-looking statements under applicable securities laws. Any statements that are contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Forward looking statements are often identified by terms such as "may", "should", "anticipate", "expect", "potential", "believe", "intend" or the negative of these terms and similar expressions. Forward-looking statements necessarily involve known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such forward-looking statements. Readers are cautioned not to place undue reliance on forward-looking statements as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. The forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities laws. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement.
Not for distribution to United States newswire services or for dissemination in the United States.
https://www.newsfilecorp.com/release/90298
oliverhugo
5年前
The Hash Corporation Enters into Collaboration Agreement with Medz Cannabis Incorporated, to Enter the Regulated Cannabis Industry
by The Hash Corporation | Apr 21, 2020 | News
Toronto, Ontario–(Newsfile Corp. – April 21, 2020) – The Hash Corporation (the “Company”, or “HashCo”), a Canadian company positioning itself to focus on the production and sale of cannabis-based hashish and other cannabis products, is pleased to announce that it has entered into a long-term collaboration agreement (the “Collaboration Agreement”) with Medz Cannabis Incorporated (“Medz Cannabis”), an Ontario-based, privately-owned company licensed for the cultivation, processing and sale of medical cannabis under the Cannabis Act. The Collaboration Agreement, which opens up opportunities in the regulated cannabis industry within Canada for the Company, is expected to enable the Company to deliver a suite of specialty hash products to the Canadian market as early as Q3 2020.
“This collaboration represents a significant step towards bringing our suite of unique products to the discerning Canadian consumer. We are extremely thrilled to work with Medz Cannabis to secure the requisite approvals, and expect to generate revenue from the Processing Space in the near term,” said Chris Savoie, Chief Executive Officer of the Company.
Under the terms of the Collaboration Agreement, Medz Cannabis will provide the Company with up to 2,500 square feet of processing space (the “Processing Space“) within a licensed facility owned by Medz Cannabis and located in Toronto, Ontario (the “Facility“), to process, package and distribute cannabis-based hashish and other cannabis concentrates (collectively, the “Products“). In addition, Medz Cannabis will assist the Company in obtaining the requisite regulatory approvals to produce and sell the Products and make use of the Processing Space, and supply the Company with cannabis bi-products and biomass required by the Company to produce the Products. Under the terms of the Collaboration Agreement, the Company will pay to Medz Cannabis a 3.5% royalty on all revenues generated on the sale of the Products produced in the Processing Space (the “Subject Products“), and a 5% royalty on the tolling or service rate charged by the Company on service contracts relating to the Subject Products.
In connection with the Collaboration Agreement, the parties have also entered into an offer to lease in respect of the Processing Space. The parties are expected to enter into a formal lease agreement, as well as a supply and branding agreement in due course, to set out certain additional terms on which the Company will make use of the Processing Space, and the terms on which the Company and Medz Cannabis will process and sell the Products.
About The Hash Corporation
HashCo is a Canadian company positioning itself to focus on the production and sale of cannabis-based hashish and other cannabis products. HashCo intends to apply its separation and curing techniques to produce a suite of high-quality cannabis resin products, which are all-natural and free of additives and carcinogenic solvents. The Company intends to tailor its product offerings to pay tribute to historic traditions, fragrances and tastes, while upholding the highest health and safety standards.
As of the date of this press release, HashCo is actively seeking and developing partnerships and collaborations with licensed cultivators and other strategic partners within Canada, with the goal of crafting and introducing to the regulated market authentic products which reflect quality and innovation.
About Medz Cannabis Inc.
Medz Cannabis is a private, Ontario-based company and holder of cultivation, processing and medical sales licenses under the federal Cannabis Act. Passionate about small-batch, craft cannabis, Medz Cannabis brings a new and unrivaled level of dedication to medical cannabis in Canada. Medz Cannabis is currently in the process of completing Phase II of construction on a 35,000 square feet cannabis cultivation facility in Toronto, Ontario, which, upon completion, is expected to produce up to 5,000 kg of cannabis per year.
For additional information on The Hash Corporation:
Jesse Kline
The Hash Corporation, Chief Commercial Officer
1-416-986-8323
jesse@hashco.ca
www.thehashcorporation.com
Forward Looking Information
Certain statements in this press release may constitute “forward looking statements” which involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward looking statements. When used in this press release, such statements may use such words as “may”, “will”, “expect”, “believe”, “plan” and other similar terminology. Such statements reflect management’s current expectations regarding future events and speak only as of the date of this press release. The forward-looking statements involve a number of risks and uncertainties, including, but not limited to, the Company’s stage of development, capital requirements and future ability to fund operations, regulatory requirements, general economic, and market or business conditions. The forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by the Company, are inherently subject to significant business, economic, competitive, political and social uncertainties and contingencies. Many factors could cause the Company’s actual results, performance or achievements to be materially different from any future results, performance, or achievements that may be expressed or implied by such forward-looking statements. In making the forward-looking statements included in this release, the Company has made various material assumptions, including, but not limited to: obtaining regulatory approvals, general business and economic conditions, the Company’s ability to successfully secure and make use of the Processing Space and process, market and sell its products, the Company’s ability to maintain good relationships with its partners and other third parties, market competition, and the immediate and eventual impacts of Coronavirus Disease 2019 (COVID-19) on the Company’s proposed operations and financial condition, and market demand. The foregoing list of factors is not exhaustive. The Company undertakes no obligation to update publicly or revise any forward-looking statements, whether a result of new information, future results or otherwise, except as required by law. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward looking-information. The foregoing statements expressly qualify any forward-looking information contained herein.
NOT FOR DISSEMINATION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES
https://www.newsfilecorp.com/release/54713/The-Hash-Corporation-Enters-into-Collaboration-Agreement-with-Medz-Cannabis-Incorporated-to-Enter-the-Regulated-Cannabis-Industry
oliverhugo
5年前
The Hash Corporation Enters into Collaboration Agreement with Black Rose Organics Canada Inc.
by The Hash Corporation | Mar 2, 2021 | News, Press Releases
Toronto, Ontario–(March 2, 2021) – The Hash Corporation (the “Company“, or “HashCo“), a Canadian company positioning itself to focus on the production and sale of cannabis-based hashish and other cannabis products, is pleased to announce that it has entered into a long-term collaboration agreement (the “Collaboration Agreement“) with Black Rose Organics Canada Inc. (“Black Rose“), an Ontario-based, privately-owned company licensed for the cultivation, processing and sale of cannabis under the Cannabis Act.
Under the terms of the Collaboration Agreement, Black Rose will provide the Company with up to 1,000 square feet of processing space (the “Processing Space“) within a licensed facility owned by Black Rose and located in Markham, Ontario (the “Facility“), to manufacture and distribute cannabis-based hashish and other cannabis concentrates (collectively, the “Products“). In addition, Black Rose will assist the Company in obtaining the requisite regulatory approvals to produce and sell the Products and make use of the Processing Space, and supply the Company with cannabis bi-products and biomass required by the Company to produce the Products. Under the terms of the Collaboration Agreement, the Company and Black Rose will share profits 50/50 on sales of Products at channels established by Black Rose for the Company, on sales of Products cultivated and/or branded by Black Rose, and on all tolling services provided by the Company at the Facility.
About The Hash Corporation
HashCo is a Canadian company positioning itself to focus on the production and sale of cannabis-based hashish and other cannabis products. HashCo intends to apply its separation and curing techniques to produce a suite of high-quality cannabis resin products, which are all-natural and free of additives and carcinogenic solvents. The Company intends to tailor its product offerings to pay tribute to historic traditions, fragrances and tastes, while upholding the highest health and safety standards.
As of the date of this press release, HashCo is actively seeking and developing partnerships and collaborations with licensed cultivators and other strategic partners within Canada, with the goal of crafting and introducing to the regulated market authentic products which reflect quality and innovation.
About Black Rose
Black Rose is a medicinal licensed producer founded in Toronto, Canada, with a dedicated focus on establishing a world class, craft level quality product base for the medicinal community. Using the most innovative and efficient growing techniques available, Black Rose is situating itself to redefine the level of quality standards expected in both the Canadian and international markets. Black Rose intends to establish their organic and non-organic cannabis product lines adhering to the highest standards available, through proven processes with a focused attention to detail at every step.
Through strategic partnerships with reputable licensed cannabis companies in the industry, Black Rose Organics vision is to consistently elevate the standards of quality within the regulated market, and intends to do so by using the safest and most effective processes available.
For additional information on The Hash Corporation:
Chris Savoie
The Hash Corporation, Chief Executive Officer
416-371-3697
chris@hashco.ca
www.thehashcorporation.com
Forward Looking Information
Certain statements in this press release may constitute “forward looking statements” which involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward looking statements. When used in this press release, such statements may use such words as “may”, “will”, “expect”, “believe”, “plan” and other similar terminology. Such statements reflect management’s current expectations regarding future events and speak only as of the date of this press release. The forward-looking statements involve a number of risks and uncertainties, including, but not limited to, the Company’s stage of development, capital requirements and future ability to fund operations, regulatory requirements, general economic, and market or business conditions. The forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by the Company, are inherently subject to significant business, economic, competitive, political and social uncertainties and contingencies. Many factors could cause the Company’s actual results, performance or achievements to be materially different from any future results, performance, or achievements that may be expressed or implied by such forward-looking statements. In making the forward-looking statements included in this release, the Company has made various material assumptions, including, but not limited to: obtaining regulatory approvals, general business and economic conditions, the Company’s ability to successfully secure and make use of the Processing Space and process, market and sell its products, the Company’s ability to maintain good relationships with its partners and other third parties, market competition, and the immediate and eventual impacts of Coronavirus Disease 2019 (COVID-19) on the Company’s proposed operations and financial condition, and market demand. The foregoing list of factors is not exhaustive. The Company undertakes no obligation to update publicly or revise any forward-looking statements, whether a result of new information, future results or otherwise, except as required by law. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward looking-information. The foregoing statements expressly qualify any forward-looking information contained herein.
NOT FOR DISSEMINATION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES
https://www.newsfilecorp.com/release/75867/The-Hash-Corporation-Enters-into-Collaboration-Agreement-with-Black-Rose-Organics-Canada-Inc.
oliverhugo
5年前
https://thehashcorporation.com/the-hash-corporation-enters-into-product-acquisition-agreement/
The Hash Corporation Enters into Product Acquisition Agreement
by The Hash Corporation | Apr 27, 2021 | News, Press Releases
Toronto, Ontario–(Newsfile Corp. – April 27, 2021) – The Hash Corporation (the “Company“, or “HashCo“), a Canadian company positioning itself to focus on the production and sale of cannabis-based hashish and other cannabis products, is pleased to announce that it has entered into a product acquisition agreement (the “Agreement“) with Canada House Wellness Group (CSE: CHV) (“Canada House“) and its wholly owned subsidiary, Abba Medix Corp., a licensed cultivator and processor under the Cannabis Act (“Abba“).
Under the terms of the Agreement, HashCo will sell certain cannabis materials comprised of pressed dry sift hash to Abba, through the Company’s collaboration agreement with Medz Cannabis Inc., a licensed cultivator and processor under the Cannabis Act. Upon Abba’s successful listing of purchased hash materials for sale in Quebec, the Agreement will commence and will remain in effect for a period of 12 months with the option to renew for subsequent 12 month periods.
“HashCo is extremely excited to enter into this relationship with the wonderful teams at Canada House and Abba,” commented Chris Savoie, CEO of Hashco. “This Agreement allows Hashco to leverage Abba’s established distribution channels to bring its high-quality products to hash consumers throughout the Province of Quebec.”
About The Hash Corporation
HashCo is a Canadian company positioning itself to focus on the production and sale of cannabis-based hashish and other cannabis products. HashCo intends to apply its separation and curing techniques to produce a suite of high-quality cannabis resin products, which are all-natural and free of additives and carcinogenic solvents. The Company intends to tailor its product offerings to pay tribute to historic traditions, fragrances and tastes, while upholding the highest health and safety standards.
As of the date of this press release, HashCo is actively seeking and developing partnerships and collaborations with licensed cultivators and other strategic partners within Canada, with the goal of crafting and introducing to the regulated market authentic products which reflect quality and innovation.
About Canada House Wellness Group
Canada House Wellness Group is the parent company of Abba Medix Corp., a Licensed Producer in Pickering, Ontario that produces high quality medical grade cannabis; IsoCanMed Inc., a Licensed Producer in Louiseville, Québec growing best-in-class indoor cannabis, in its 64,000 sq. ft. production facility employing state-of-the-art vertical, aeroponic production methodologies; Canada House Clinics Inc., with clinics across the country that work directly with primary care teams to provide specialized cannabinoid therapy services to patients suffering from simple and complex medical conditions; and Knalysis Technologies, a provider of fully customizable, cloud-based software that links physician, provider, and patient to data that supports treatment with medical cannabis.
Canada House Wellness Group’s goal is to become the leading cultivator of premium craft cannabis and provider of cannabinoid therapy, targeting the medical cannabis markets globally.
For additional information on The Hash Corporation:
Chris Savoie
The Hash Corporation, Chief Executive Officer
1800-420-REZN
chris@hashco.ca
www.thehashcorporation.com
Forward Looking Information
Certain statements in this press release may constitute “forward looking statements” which involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward looking statements. When used in this press release, such statements may use such words as “may”, “will”, “expect”, “believe”, “plan” and other similar terminology. Such statements reflect management’s current expectations regarding future events and speak only as of the date of this press release. The forward-looking statements involve a number of risks and uncertainties, including, but not limited to, the Company’s stage of development, capital requirements and future ability to fund operations, regulatory requirements, general economic, and market or business conditions, and the Company’s ability to carry out its obligations under the Agreement. The forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by the Company, are inherently subject to significant business, economic, competitive, political and social uncertainties and contingencies. Many factors could cause the Company’s actual results, performance or achievements to be materially different from any future results, performance, or achievements that may be expressed or implied by such forward-looking statements. In making the forward-looking statements included in this release, the Company has made various material assumptions, including, but not limited to: obtaining regulatory approvals, general business and economic conditions, the Company’s ability to successfully carry out of all its obligations under the Agreement on the terms set out in the Agreement, the purchasers’ ability to obtain approval from the Société québécoise du cannabis, the purchasers’ willingness to carry out the terms of the Agreement and purchase the Product, the Company’s ability to maintain good relationships with its partners and other third parties, market competition, and the immediate and eventual impacts of Coronavirus Disease 2019 (COVID-19) on the Company’s proposed operations and financial condition, and market demand. The foregoing list of factors is not exhaustive. The Company undertakes no obligation to update publicly or revise any forward-looking statements, whether a result of new information, future results or otherwise, except as required by law. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward looking-information. The foregoing statements expressly qualify any forward-looking information contained herein.
NOT FOR DISSEMINATION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES
https://www.newsfilecorp.com/release/81974
Hot Features
プレミアム
登録してリアルタイムのチャート、分析ツール、価格を入手してください。
メールアドレスで登録
